Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Synergy CHC Corp. (NASDAQ: SNYR) appointed Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America effective Dec. 16, 2025.

Rhea-AI Summary

Synergy CHC Corp. (NASDAQ: SNYR) appointed Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America effective Dec. 16, 2025.

Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region as Synergy advances international growth. The company established a wholly owned Mexico subsidiary in May 2025 and began initial shipments of supplement products to Costco Mexico this week. Colmenares has 18+ years of regional experience including roles at Procter & Gamble and Victus/Megalabs.

Argus Dec 16 session

-5.61% close to close 0.5x rel. volume Open Argus

Details

News Market Reaction – SNYR

On Dec 16, the day this news came out, SNYR closed 5.61% below the previous close.

Data tracked by StockTitan Argus for the Dec 16 session.

Key Figures

Industry experience: over 18 years

Industry experience

over 18 years

Pedro Colmenares’ experience across pharmaceutical and consumer health sectors

Historical Context

5 past events · Latest: Nov 13

5 events

1. Nov 13

   Q3 2025 earnings

   24h Move

   -6.4%

   Reported 11th straight profitable quarter with higher revenue and margins.

2. Nov 05

   Distribution partnership

   24h Move

   +4.6%

   Announced new C&M Sales partnership to expand FOCUSfactor beverages in Arkansas.

3. Oct 30

   Earnings call notice

   24h Move

   +3.1%

   Set date and time for Q3 2025 results release and conference call.

4. Oct 27

   Brand recognition

   24h Move

   -3.3%

   FOCUSfactor named #1 pharmacist recommended OTC memory supplement for 2025-2026.

5. Oct 22

   Retail expansion

   24h Move

   +6.3%

   Disclosed expanded FOCUSfactor distribution across major U.S., Canadian and global retailers.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

wholly owned subsidiary, otc, omnichannel, go-to-market

4 terms

wholly owned subsidiary financial

"Synergy established a wholly owned subsidiary in Mexico and has begun its initial market entry"

A wholly owned subsidiary is a company whose entire ownership is held by another company (the parent), so the parent controls decisions, operations, and finances. Think of it as a fully controlled branch that runs as its own legal entity but whose results flow straight into the parent’s financial statements; investors watch these structures because they affect consolidated revenue, risk exposure, and how profits, liabilities, and cash flow are allocated across the corporate group.

otc regulatory

"across the pharmaceutical, nutraceutical, OTC, and consumer health sectors"

OTC stands for "over-the-counter" and describes securities that trade directly between dealers or via dealer networks rather than on a formal stock exchange. It matters to investors because OTC listings typically have fewer reporting rules and lower trading volume, which can mean higher price swings, limited liquidity, and greater difficulty buying or selling shares—similar to shopping at a small flea market instead of a large, regulated supermarket.

View in glossary

omnichannel technical

"built scaled regional sales, marketing, and distribution platforms through strategic partnerships and omnichannel execution"

A coordinated approach to selling and serving customers across all touchpoints—stores, websites, mobile apps, social media, and call centers—so the experience feels like one continuous conversation no matter where a customer interacts. For investors, omnichannel capability signals how well a company can attract and keep customers, turn interactions into sales, and use shared customer data to cut costs and boost revenue—making it a key driver of growth and competitive strength.

go-to-market technical

"lead commercial strategy, market expansion, and go-to-market execution across the region"

A go-to-market plan is the practical roadmap a company uses to introduce a product or service to customers, covering who the target buyers are, how the product will be sold or distributed, pricing, and the main marketing and sales messages. For investors, it shows how quickly and cost-effectively a business can win customers and generate revenue — like a launch playbook that determines whether a new offering will reach its audience and scale profitably.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Role Supports Synergy’s Expanding Presence in Mexico, Including Initial Product Shipments to Costco Mexico

WESTBROOK, Maine, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced that Pedro Colmenares has been appointed Director of Sales & Marketing for Mexico & Latin America. In this role, Mr. Colmenares will lead commercial strategy, market expansion, and go-to-market execution across the region.

Mr. Colmenares joins the Company at a pivotal time as it advances its international growth strategy. As announced in May 2025, Synergy established a wholly owned subsidiary in Mexico and has begun its initial market entry through shipments of its supplement products to Costco Mexico this week. As Director of Sales and Marketing for Mexico and Latin America, he will play a central role in executing this strategy and driving growth across both the Company’s supplement and functional beverage portfolios, building a scalable commercial foundation to support long-term growth.

“We’re excited to welcome Pedro to the Synergy team as we accelerate our expansion in Mexico and the broader Latin American market,” said Jack Ross, CEO of Synergy CHC Corp. “He brings deep regional expertise and a proven ability to build scalable commercial platforms from the ground up. His experience launching operations, developing distribution networks, and driving sustainable growth across Latin America will be instrumental as we establish and expand our presence in these high-potential markets.”

Mr. Colmenares is a senior commercial executive with over 18 years of experience across the pharmaceutical, nutraceutical, OTC, and consumer health sectors. He has successfully led market entry and expansion initiatives throughout Mexico and Latin America, consistently transforming underdeveloped markets into high-performing, sustainable businesses. His background includes leadership roles at Procter & Gamble and Victus/Megalabs, where he built scaled regional sales, marketing, and distribution platforms through strategic partnerships and omnichannel execution.

Throughout his career, Mr. Colmenares has launched and developed operations in multiple countries across Latin America, driving accelerated growth through disciplined go-to-market strategies, localized brand development, and strong retailer and supplier relationships. His experience spans both multinational and regional organizations, providing a deep understanding of the operational and cultural dynamics required to scale consumer health brands in the region.

Pedro Colmenares commented: “I’m excited to join Synergy at such an important stage in the Company’s expansion. Synergy’s flagship FOCUSfactor brand, combined with its commitment to disciplined growth and local execution, presents a compelling opportunity. I look forward to building strong partnerships and helping drive meaningful, sustainable growth across Mexico and Latin America.”

About Synergy CHC Corp.

Synergy CHC Corp. develops and markets consumer health and wellness products, led by its flagship brands FOCUSfactor^® and Flat Tummy^®. FOCUSfactor^®, a clinically studied brain health supplement and functional beverage line with a 25-year legacy, enjoys established distribution in the U.S., Canada, and the U.K. through major retailers including Costco, Walmart, Amazon, BJ's, and Walgreens, among others. The brand continues to accelerate growth, penetrating new markets both domestically and internationally, with recent retail wins across mass, grocery, pharmacy, convenience, and wholesale channels poised to drive meaningful gains in late 2025. Flat Tummy^® complements Synergy's portfolio as a lifestyle brand focused on women's wellness and weight management.

Investor Relations
Gateway Group
Cody Slach, Greg Robles
949.574.3860
SNYR@gateway-grp.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is Pedro Colmenares and what role was he hired for at Synergy (SNYR)?

Pedro Colmenares was appointed Director of Sales & Marketing for Mexico & Latin America, responsible for commercial strategy and market expansion.

When did Synergy (SNYR) announce the appointment of Pedro Colmenares?

The appointment was announced on December 16, 2025.

What recent market steps has Synergy (SNYR) taken in Mexico?

Synergy established a wholly owned subsidiary in Mexico in May 2025 and began initial shipments to Costco Mexico this week.

How much regional experience does the new director have relevant to Synergy (SNYR)?

Mr. Colmenares has over 18 years of experience across pharmaceutical, nutraceutical, OTC, and consumer health sectors in Latin America.

Which Synergy product lines will Pedro Colmenares focus on in Mexico and Latin America?

He will focus on the company’s supplement and functional beverage portfolios, including the FOCUSfactor brand.

How will Pedro Colmenares support Synergy’s expansion in Latin America?

He will build commercial strategy, distribution networks, and go-to-market execution to scale operations and drive growth across the region.